Tammineni Prasad, Jeong Yu Young, Feng Tuancheng, Aikal Daniyal, Cai Qian
Department of Cell Biology and Neuroscience, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA.
Hum Mol Genet. 2017 Nov 15;26(22):4352-4366. doi: 10.1093/hmg/ddx321.
Lysosomal proteolysis is essential for the quality control of intracellular components and the maintenance of cellular homeostasis. Lysosomal alterations have been implicated as one of the main cellular defects contributing to the onset and progression of Alzheimer's disease (AD). However, the mechanism underlying lysosomal deficits in AD remains poorly understood. Here, we reveal that lysosomal deficits are attributed to retromer dysfunction induced by altered retromer trafficking in the axon of AD-related mutant human amyloid precursor protein (hAPP) transgenic (Tg) mouse neurons. We demonstrate that retrograde transport of retromer is impaired, leading to its significant reduction in the soma and abnormal retention within late endosomes in distal axons of mutant hAPP neurons. Therefore, retromer-mediated endosome-to-Golgi retrieval of cation-independent mannose-6-phosphate receptors (CI-MPR) in the soma is disrupted in mutant hAPP neurons, causing defects in lysosome biogenesis. Such defects result in protease deficiency in lysosomes and impaired lysosomal proteolysis, as evidenced by aberrant accumulation of sequestered substrates within lysosomes. Intriguingly, enhancement of retrograde transport in mutant hAPP neurons facilitates the trafficking of axonal retromer toward the soma and thus enhances protease transport to lysosomes, thereby restoring lysosomal proteolytic activity. Taken together, our study provides new insights into the regulation of retromer trafficking through retrograde axonal transport to fulfil its function in promoting lysosome biogenesis in the soma, suggesting a potential approach for rescuing lysosomal proteolysis deficits in AD.
溶酶体蛋白水解对于细胞内成分的质量控制和细胞稳态的维持至关重要。溶酶体改变被认为是导致阿尔茨海默病(AD)发生和进展的主要细胞缺陷之一。然而,AD中溶酶体缺陷的潜在机制仍知之甚少。在此,我们揭示溶酶体缺陷归因于AD相关突变型人类淀粉样前体蛋白(hAPP)转基因(Tg)小鼠神经元轴突中retromer运输改变所诱导的retromer功能障碍。我们证明retromer的逆行运输受损,导致其在胞体中显著减少,并在突变型hAPP神经元远端轴突的晚期内体中异常滞留。因此,retromer介导的胞体中阳离子非依赖性甘露糖-6-磷酸受体(CI-MPR)从内体到高尔基体的回收在突变型hAPP神经元中被破坏,导致溶酶体生物发生缺陷。这些缺陷导致溶酶体中蛋白酶缺乏和溶酶体蛋白水解受损,溶酶体内隔离底物的异常积累证明了这一点。有趣的是,增强突变型hAPP神经元中的逆行运输促进轴突retromer向胞体的运输,从而增强蛋白酶向溶酶体的运输,从而恢复溶酶体蛋白水解活性。综上所述,我们的研究为通过轴突逆行运输调节retromer运输以实现其在促进胞体溶酶体生物发生中的功能提供了新的见解,提示了一种挽救AD中溶酶体蛋白水解缺陷的潜在方法。